Related Experiment Video
Updated: Mar 13, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
Maryam Barma1,2, Faisel Khan3, Rosemary J G Price3
1Division of Cardiovascular and Diabetes Medicine, University of Dundee, Dundee, UK. m.barma@dundee.ac.uk.
Background:
Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension.
Aims:
To correlate baseline GDF-15 levels with physical and vascular health data in this population.
Methods:
Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed.
Results:
A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log10GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = -0.33, p < 0.001) and 6-min walking distance (r = -0.37, p < 0.001). Age remained significantly associated with log10GDF-15 in multivariable analysis (beta = -0.29, p = 0.001). Baseline log10GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = -0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months.
Conclusion:
Baseline GDF-15 predicts declining physical, but not vascular, function in our population.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Hypertension and Regulation of Blood Pressure
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Hypertension III: Clinical Manifestations and Diagnostic Studies

